GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.0870
+0.0020 (2.35%)
At close: Mar 13, 2026
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €19.18 million as of March 13, 2026. Its market cap has decreased by -27.79% in one year.
Market Cap
19.18M
Enterprise Value
37.93M
Revenue
945.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.09
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 19.18M, a decrease of -92.39%. That is a compound annual growth rate of -23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 19.18M | -16.67% |
| Dec 31, 2025 | 23.02M | -30.35% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| THX Pharma Société Anonyme | 44.84M |
| Nicox | 38.65M |
| Fermentalg | 37.36M |
| Advicenne | 27.49M |
| genOway Société anonyme | 21.94M |
| Aelis Farma | 18.49M |
| NFL Biosciences | 13.94M |
| Poxel | 13.65M |